Conclusion The interrelationship between PsD and its metabolic comorbidities namely obesity, T2DM, and CV disease is increasingly recognized as a critical determinant of patient outcomes requiring multidisciplinary management
Certain individuals are at a higher risk for developing colon cancer, including those with a family history of colon cancer or colon polyps, a personal history of precancerous colon polyps, African Americans, some Jewish groups, and individuals with inflammatory bowel diseases like Crohn's disease or ulcerative colitis
But for a lot of people, these meds are not just appropriate, theyre overdue
The recommendations were published in a Concise Clinical Guidance statement, designed to give clinicians a framework for managing obesity using the ever-expanding set of tools now available
Patients taking insulin or sulfonylureas should consult their healthcare provider before changing meal timing, as these medications increase hypoglycemia risk